What's breaking now, across thousands of outlets.
A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is resistant to some commonly used HIV drugs, according to a new UC San Francisco study.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Researchers report encouraging findings from the first clinical cohort of blind people treated with optogenetic therapy The post Optogenetic therapy shows promise for vision restoration appeared first…
A team of hearing specialists at Vanderbilt Health analyzed thousands of data samples in the institution's BioVU biobank to understand genetic susceptibility of sensorineural hearing loss, which is…
X-ray of a seven-year-old’s jaw. (–1001-/iStockphoto/Getty Images) Here’s what we know. Don't miss a story, subscribe here.
More than half of LGBTQ+ adults in Massachusetts experienced food insecurity in 2024, according to a new study published in JAMA Network Open.
Grindr tested the healthcare waters last year when it launched a telehealth partnership that connected users to clinicians for prescription erectile dysfunction and weight loss drugs.
The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents.
